ATI RN
ATI RN Comprehensive Exit Exam
1. A nurse is planning care for a client who has diabetes insipidus and is receiving desmopressin. Which of the following should the nurse monitor?
- A. Fasting blood glucose
- B. Carbohydrate intake
- C. Hematocrit
- D. Weight
Correct answer: D
Rationale: The correct answer is D: Weight. Weight monitoring is essential to assess the effectiveness of desmopressin therapy, as fluid retention is a common side effect. Monitoring fasting blood glucose (choice A) is not directly related to desmopressin therapy for diabetes insipidus. Monitoring carbohydrate intake (choice B) may be important in diabetes management but is not specific to desmopressin therapy. Hematocrit (choice C) monitoring is not a primary concern when managing diabetes insipidus with desmopressin.
2. A client who had a colon resection and a new ascending colostomy is receiving discharge teaching from a nurse. Which of the following statements by the client indicates an understanding of the teaching?
- A. My stool will become fully formed within 3 weeks.
- B. My skin should be cleaned with alcohol before applying a new pouch.
- C. I should avoid eating popcorn and fresh pineapple.
- D. I should expect bruising around the stoma.
Correct answer: C
Rationale: The correct answer is C because avoiding popcorn and fresh pineapple helps prevent complications with an ascending colostomy. Statements A, B, and D are incorrect. Statement A is inaccurate as it takes time for bowel function to normalize after surgery. Statement B is incorrect as alcohol can be irritating to the skin; gentle soap and water are recommended for cleaning. Statement D is incorrect as bruising around the stoma is not an expected outcome of colostomy creation.
3. A nurse is assisting with the development of an informed document for participation in a research study. Which of the following information should the nurse include?
- A. A statement that participants can leave the study at will.
- B. An assignment of the participant to either the experimental or control group.
- C. A list of the clients participating in the study.
- D. A description of the framework the researchers will use to evaluate the data.
Correct answer: A
Rationale: The correct answer is A: 'A statement that participants can leave the study at will.' This information is crucial to include in the informed document to ensure that participants are aware of their right to withdraw from the study at any time without any negative consequences. Choice B is incorrect because participants should not be assigned to experimental or control groups without their knowledge and consent. Choice C is incorrect because disclosing a list of clients participating in the study violates confidentiality. Choice D is incorrect as the description of the data evaluation framework is important but not as critical as ensuring participants know they can leave the study at will.
4. What is the most important nursing intervention for a patient with a suspected pulmonary embolism?
- A. Administer anticoagulants
- B. Administer oxygen
- C. Reposition the patient
- D. Monitor oxygen saturation
Correct answer: A
Rationale: The most important nursing intervention for a patient with a suspected pulmonary embolism is to administer anticoagulants. Anticoagulants help prevent further clot formation in the patient's blood vessels, reducing the risk of complications such as worsening of the pulmonary embolism or development of new clots. Administering oxygen (Choice B) may be necessary to support the patient's oxygenation, but anticoagulants take precedence as they target the underlying cause of the pulmonary embolism. Repositioning the patient (Choice C) and monitoring oxygen saturation (Choice D) are important aspects of patient care but are not the primary intervention for a suspected pulmonary embolism.
5. Which of the following is a sign of digoxin toxicity?
- A. Bradycardia
- B. Hypertension
- C. Tachycardia
- D. Tachypnea
Correct answer: A
Rationale: The correct answer is A, Bradycardia. Bradycardia, or a slower than normal heart rate, is a classic sign of digoxin toxicity. Digoxin is a medication commonly used to treat heart conditions, but an excess of digoxin in the body can lead to toxicity. This toxicity can manifest as various symptoms, with bradycardia being one of the most common ones. Hypertension (high blood pressure) and tachycardia (fast heart rate) are not typical signs of digoxin toxicity. Tachypnea, which refers to rapid breathing, is also not a common sign of digoxin toxicity.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access